Concepedia
Author
Paulatsya Joshi
Also Known As
5
Publications
177
Citations
2
H-Index
Concepts
All Affiliations
1
128
×
All Concepts
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
Alexa B. Kimball, Gregor B. E. Jemec, Christopher J. Sayed, +17
The Lancet
Moderate-to-severe Hidradenitis SuppurativaBe Heard IiBe HeardClinical DermatologyDermatology +1
2024
Randomised Clinical Trial Investigating the Specificity of a Novel Skin Test (C-Tb) for Diagnosis of M. tuberculosis Infection
Henrik Aggerbeck, Rafaela Giemza, Paulatsya Joshi, +5
PLoS ONE
2013
49
Page 1